Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections.

acute infection anemia of inflammation functional iron deficiency hepcidin i-FGF23

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
17 Sep 2024
Historique:
received: 24 08 2024
revised: 10 09 2024
accepted: 13 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

We intend to evaluate the association of intact Fibroblast Growth Factor 23 (i-FGF23), a phosphaturic hormone that contributes to anemia of inflammation, with markers of iron homeostasis, inflammation, and bone mineral metabolism in acute pediatric infections. Seventy-nine children, aged 1 month-13 years, out of which forty-two were males and thirty-seven females, participated in this study. Children with diseases and nutrient deficiencies causing anemia were excluded. Twenty-six patients had bacterial infections, twenty-six had viral infections, and twenty-seven children served as healthy controls. Complete blood count, markers of inflammation, iron and mineral metabolism, serum hepcidin, and i-FGF23 were compared between the groups. Thirty-nine percent of patients with bacterial infection and twelve percent of patients with viral infection presented characteristics of anemia of inflammation (

Identifiants

pubmed: 39336155
pii: biology13090728
doi: 10.3390/biology13090728
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Eleni Papastergiou (E)

Department of Pediatrics, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, Postgraduate Program "Hematology-Oncology in Childhood and Adolescence" of Medical School, University of Crete, 71003 Heraklion, Greece.

Dimitrios Rallis (D)

Neonatal Intensive Care Unit, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Afroditi Papagianni (A)

Laboratory of Child Health, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Vasileios Cholevas (V)

Laboratory of Child Health, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Nikolaos Katzilakis (N)

Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, Postgraduate Program "Hematology-Oncology in Childhood and Adolescence" of Medical School, University of Crete, 71003 Heraklion, Greece.

Ekaterini Siomou (E)

Department of Pediatrics, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Eftichia Stiakaki (E)

Department of Pediatric Hematology-Oncology, University Hospital of Heraklion, Postgraduate Program "Hematology-Oncology in Childhood and Adolescence" of Medical School, University of Crete, 71003 Heraklion, Greece.

Alexandros Makis (A)

Department of Pediatrics, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Laboratory of Child Health, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.

Classifications MeSH